1. Home
  2. SERA vs JRVR Comparison

SERA vs JRVR Comparison

Compare SERA & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • JRVR
  • Stock Information
  • Founded
  • SERA 2008
  • JRVR 2002
  • Country
  • SERA United States
  • JRVR Bermuda
  • Employees
  • SERA N/A
  • JRVR N/A
  • Industry
  • SERA Precision Instruments
  • JRVR Property-Casualty Insurers
  • Sector
  • SERA Health Care
  • JRVR Finance
  • Exchange
  • SERA Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • SERA 208.7M
  • JRVR 241.0M
  • IPO Year
  • SERA 2021
  • JRVR 2005
  • Fundamental
  • Price
  • SERA $8.35
  • JRVR $4.61
  • Analyst Decision
  • SERA
  • JRVR Buy
  • Analyst Count
  • SERA 0
  • JRVR 5
  • Target Price
  • SERA N/A
  • JRVR $10.40
  • AVG Volume (30 Days)
  • SERA 79.3K
  • JRVR 343.3K
  • Earning Date
  • SERA 11-06-2024
  • JRVR 11-11-2024
  • Dividend Yield
  • SERA N/A
  • JRVR 3.43%
  • EPS Growth
  • SERA N/A
  • JRVR N/A
  • EPS
  • SERA N/A
  • JRVR N/A
  • Revenue
  • SERA $94,000.00
  • JRVR $796,817,000.00
  • Revenue This Year
  • SERA N/A
  • JRVR N/A
  • Revenue Next Year
  • SERA $4,471.43
  • JRVR $7.46
  • P/E Ratio
  • SERA N/A
  • JRVR N/A
  • Revenue Growth
  • SERA N/A
  • JRVR 19.38
  • 52 Week Low
  • SERA $4.90
  • JRVR $4.35
  • 52 Week High
  • SERA $12.36
  • JRVR $11.49
  • Technical
  • Relative Strength Index (RSI)
  • SERA 57.84
  • JRVR 42.21
  • Support Level
  • SERA $7.91
  • JRVR $4.40
  • Resistance Level
  • SERA $8.60
  • JRVR $4.77
  • Average True Range (ATR)
  • SERA 0.58
  • JRVR 0.21
  • MACD
  • SERA 0.07
  • JRVR 0.06
  • Stochastic Oscillator
  • SERA 67.96
  • JRVR 39.62

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure. and the Corporate and other segment consists of the management and treasury activities of holding companies, equity compensation for the group.

Share on Social Networks: